Literature DB >> 31742498

Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.

Sawsan I Khdair1, Wassan Jarrar1, Yazun Bashir Jarrar1, Safa'a Bataineh2, Omar Al-Khaldi2.   

Abstract

BACKGROUND: The Human Leukocyte Antigen (HLA) class II genes, particularly the HLADR and -DQ loci, have been shown to play a crucial role in Type 1 Diabetes (T1D) development.
OBJECTIVE: This study is the first to examine the contribution of the HLA-DR/DQ alleles and haplotypes to T1D susceptibility in Jordanians.
METHODS: Polymerase chain reaction sequence-specific primers (PCR-SSP) were used to genotype 41 Jordanian healthy controls and 50 insulin-dependent diabetes mellitus (IDDM) patients.
RESULTS: The following alleles were found to be significant high risk alleles in T1D Jordanian patients: DRB1*04 (OR=3.95, p<0.001), DRB1*0301(OR=5.27, p<0.001), DQA1*0301 (OR=5.67, p<0.001), DQA1*0501(OR=3.18, p=0.002), DQB1*0201(OR=2.18, p=0.03), DQB1*0302 (OR=5.67, p<0.001). However, Jordanians harboring the DRB1*0701 (OR=0.37, p=0.01), DRB1*1101 (OR=0.2, p=0.01), DQA1*0505 (OR=0.31, p=0.02), DQA1*0103 (OR=0.33, p=0.04), DQA1*0201 (OR=0.45, p=0.04), DQB1*0301 (OR=0.23, p=0.001), DQB1*0501 (OR=0.18, p=0.009) alleles had a significantly lower risk of developing T1D.
CONCLUSION: A strong positive association of DRB1*04-DQA1*0301-DQBl*0302 (OR=5.67, p<0.001) and DRB1*0301-DQA1*0501-DQB1*0201 (OR=6.24, p<0.001) putative haplotypes with IDDM was evident in Jordanian IDDM patients whereas DRB1*1101-DQA1*0505- DQB1*0301 (OR=0.23, p=0.03) was shown to have a protective role against T1D in Jordanians. Our findings show that specific HLA class II alleles and haplotypes are significantly associated with susceptibility to T1D in Jordanians. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  HLA-DQA1; HLA-DRB1; HLADQB1; Insulin-dependent diabetes mellitus (IDDM); Jordanians; Type 1 diabetes mellitus (T1D)

Mesh:

Substances:

Year:  2020        PMID: 31742498     DOI: 10.2174/1871530319666191119114031

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

1.  Sintilimab-induced autoimmune diabetes: A case report and review of the literature.

Authors:  Jing Yang; Ying Wang; Xiang-Min Tong
Journal:  World J Clin Cases       Date:  2022-02-06       Impact factor: 1.337

2.  Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.

Authors:  Liang Wen; Xiuwen Zou; Yiwen Chen; Xueli Bai; Tingbo Liang
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

3.  Knowledge and attitudes regarding genetic testing among Jordanians: An approach towards genomic medicine.

Authors:  Sawsan I Khdair; Walid Al-Qerem; Wassan Jarrar
Journal:  Saudi J Biol Sci       Date:  2021-04-20       Impact factor: 4.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.